Literature DB >> 7590988

A polymorphic dinucleotide repeat in the human IL-10 promoter.

J Eskdale1, G Gallagher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7590988     DOI： 10.1007/BF00179416

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  9 in total

1.  Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.

Authors:  C Wanidworanun; W Strober
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

2.  The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.

Authors:  U Lüscher; L Filgueira; A Juretic; M Zuber; N J Lüscher; M Heberer; G C Spagnoli
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

3.  Highly informative typing of the human TNF locus using six adjacent polymorphic markers.

Authors:  I A Udalova; S A Nedospasov; G C Webb; D D Chaplin; R L Turetskaya
Journal:  Genomics       Date:  1993-04       Impact factor: 5.736

4.  Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations.

Authors:  D G Marsh; J D Neely; D R Breazeale; B Ghosh; L R Freidhoff; E Ehrlich-Kautzky; C Schou; G Krishnaswamy; T H Beaty
Journal:  Science       Date:  1994-05-20       Impact factor: 47.728

5.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.

Authors:  F Pociot; L Briant; C V Jongeneel; J Mölvig; H Worsaae; M Abbal; M Thomsen; J Nerup; A Cambon-Thomsen
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

Review 6.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

7.  Elevated interleukin-10 levels in patients with rheumatoid arthritis.

Authors:  J J Cush; J B Splawski; R Thomas; J E McFarlin; H Schulze-Koops; L S Davis; K Fujita; P E Lipsky
Journal:  Arthritis Rheum       Date:  1995-01

8.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

9.  Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.

Authors:  D Kube; C Platzer; A von Knethen; H Straub; H Bohlen; M Hafner; H Tesch
Journal:  Cytokine       Date:  1995-01       Impact factor: 3.861
  9 in total
  27 in total

1.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma.

Authors:  Maja A Hofmann; Felix Kiecker; Ingeborg Küchler; Christian Kors; Uwe Trefzer
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-09       Impact factor: 4.553

3.  IL10 gene polymorphisms are associated with asthma phenotypes in children.

Authors:  Helen Lyon; Christoph Lange; Stephen Lake; Edwin K Silverman; Adrienne G Randolph; David Kwiatkowski; Benjamin A Raby; Ross Lazarus; Katy M Weiland; Nan Laird; Scott T Weiss
Journal:  Genet Epidemiol       Date:  2004-02       Impact factor: 2.135

4.  Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Authors:  Spaska A Stanilova; Lyuba D Miteva; Zhivko T Karakolev; Chavdar S Stefanov
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

Review 5.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

6.  Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population.

Authors:  Fanjun Kong; Jie Liu; Yongheng Liu; Bao Song; Hualing Wang; Wenchao Liu
Journal:  J Exp Clin Cancer Res       Date:  2010-06-17

7.  Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.

Authors:  Jie Liu; Bao Song; Xueli Bai; Wenjian Liu; Zengjun Li; Jialin Wang; Yan Zheng; Zhehai Wang
Journal:  BMC Cancer       Date:  2010-08-24       Impact factor: 4.430

8.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes.

Authors:  J Eskdale; G Gallagher; C L Verweij; V Keijsers; R G Westendorp; T W Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis.

Authors:  H Schotte; B Schlüter; S Drynda; P Willeke; N Tidow; G Assmann; W Domschke; J Kekow; M Gaubitz
Journal:  Ann Rheum Dis       Date:  2004-09-02       Impact factor: 19.103

10.  Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.

Authors:  Susanne Knapp; Branwen J W Hennig; Angela J Frodsham; Lyna Zhang; Simon Hellier; Mark Wright; Rob Goldin; Adrian V S Hill; Howard C Thomas; Mark R Thursz
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.